Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial

Bell Kirstine J.; Gray Robyn; Munns Diane; Petocz Peter; Steil Garry; Howard Gabrielle; Colagiuri Stephen; Brand-Miller Jennie C.

首页> 外文期刊>Diabetes technology & therapeutics >Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial

【24h】

Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial

机译：食品胰岛素指数在成人1型糖尿病患者进餐时胰岛素的临床应用：随机对照试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: The Food Insulin Index (FII) is a novel algorithm for ranking foods based on their insulin demand relative to an isoenergetic reference food. We compared the effect of carbohydrate counting (CC) versus the FII algorithm for estimating insulin dosage on glycemic control in type 1 diabetes.

机译：背景：食品胰岛素指数（FII）是一种用于根据相对于同能参考食品的胰岛素需求对食品进行排名的新颖算法。我们比较了碳水化合物计数（CC）和FII算法对1型糖尿病患者血糖控制中胰岛素剂量估算的影响。

著录项

来源
《Diabetes technology & therapeutics》 |2016年第4期|共8页
作者
Bell Kirstine J.; Gray Robyn; Munns Diane; Petocz Peter; Steil Garry; Howard Gabrielle; Colagiuri Stephen; Brand-Miller Jennie C.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial [J] . Bell Kirstine J., Gray Robyn, Munns Diane, Diabetes technology & therapeutics . 2016,第4期

机译：食品胰岛素指数在成人1型糖尿病患者进餐时胰岛素的临床应用：随机对照试验
2. New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1) [J] . Matsuhisa M., Koyama M., Cheng X., Diabetes, obesity & metabolism . 2016,第4期

机译：在日本使用基础和进餐时间胰岛素的1型糖尿病成年人中，新的甘精胰岛素300 U / ml与甘精胰岛素100 U / ml的对比：一项随机对照试验（EDITION JP 1）中的血糖控制和低血糖
3. Evaluation of a novel continuous glucose monitoring-based method for mealtime insulin dosing-The iBolus-In subjects with type 1 diabetes using continuous subcutaneous insulin infusion therapy: A randomized controlled trial [J] . RossettiP., Ampudia-BlascoF.J., LagunaA., Diabetes technology & therapeutics . 2012,第11期

机译：评估基于进餐时间胰岛素剂量的新型基于连续葡萄糖监测的方法-使用连续皮下胰岛素输注治疗的iBolus-In型1型糖尿病患者：一项随机对照试验
4. Long-acting Insulin in Diabetes Therapy: In Silico Clinical Trials with the UVA/Padova Type 1 Diabetes Simulator^* [C] . Roberto Visentin, Michele Schiavon, Clemens Giegerich, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2018

机译：长效胰岛素在糖尿病治疗中的作用：采用UVA / Padova 1型糖尿病模拟器的Silico临床试验^*
5. A 4-month randomized controlled clinical trial of adjuvant Exenatide or Pramlintide versus insulin alone in pediatric type 1 diabetes mellitus: Effect on glycemic control. [D] . Withycombe, Sarah Elizabeth. 2010

机译：儿科1型糖尿病患者中艾塞那肽或普兰林肽与单独使用胰岛素的4个月随机对照临床试验：对血糖控制的影响。
6. Short Report: Treatment Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN® Basal–Bolus Type 1): 2-year results of a randomized clinical trial [O] . B W Bode, J B Buse, M Fisher, -1

机译：简短报告：在1型糖尿病（BEGIN®Basal-Bolus 1型）中就餐时服用门冬胰岛素的基础-大剂量治疗胰岛素地格曲德改善血糖控制的夜间低血糖风险低于甘精胰岛素其2年随机临床试验结果
7. Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal–bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN ® Basal–Bolus Type 1): 2‐year results of a randomized clinical trial [O] . B. W. Bode, J. B. Buse, M. Fisher, 2013

机译：胰岛素Degludec在基底胰岛素Aspart在1型糖尿病（Begin®Basal-Zolus 1）中的胰岛素胰岛素中，胰岛素Degludec提高了夜间低血糖症的风险低于胰岛素胰岛素的血糖控制：2年的随机临床试验结果

Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial

摘要

著录项

相似文献

相关主题

期刊订阅